🇺🇸 FDA
Patent

US 8093214

Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

granted A61KA61K31/21A61K38/2292

Quick answer

US patent 8093214 (Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERX BIOPHARMACEUTICALS, INC.
Grant date
Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/21, A61K38/2292, A61P, A61P9/00